— Know what they know.
Not Investment Advice
Also trades as: 0QAH.L (LSE) · $vol 5M · 6MK.DE (XETRA) · $vol 0M · MRK.TO (TSX) · $vol 0M · MRK.PA (PAR) · $vol 0M

MRK NYSE

Merck & Co., Inc.
1W: -3.0% 1M: -4.3% 3M: +13.8% YTD: +35.6% 1Y: +61.5% 3Y: +49.1% 5Y: +123.8%
$144.30
+0.49 (+0.34%)
 
Weekly Expected Move ±2.6%
$137 $141 $144 $148 $152
NYSE · Healthcare · Drug Manufacturers - General · Tech Score Neutral · Power 53 · $356.4B mcap · 2.47B float · 0.430% daily turnover · Short 29% of daily vol

Supply Chain Overview

3 relationships
1
As Filer
counterparties named
2
As Counterparty
mentioned by others
1
Rel. Types
2021-06-03
Earliest Filing
2023-10-31
Latest Filing
target: 1

Counterparties (Filed by MRK)

1 relationships

Companies named in MRK's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Organon & Co. OGN target Separation of women's health, biosimilars and established brands businesses into a separate publicly-traded company 2021-06-03 View

Mentioned As Counterparty

2 mentions

Other companies that named MRK in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
RNTX AILERON THERAPEUTICS INC partner Company that acquired Peloton Therapeutics Inc. 2023-10-31 View
OGN Organon & Co. partner Partner in separation and distribution agreement; spin-off of women's health and biosimilars business. 2021-06-03 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-04 Earnings Release; Exhibits View
2026-05-28 Shareholder Vote View
2026-05-22 Other Events; Exhibits View
2026-04-30 Earnings Release; Exhibits View
2026-02-03 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-12-04 Other Events; Financial Statements and Exhibits View
2025-10-30 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-09-09 Other Events; Financial Statements and Exhibits View
2025-07-29 Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities; Fi View
2025-05-29 Submission of Matters to a Vote of Security Holders View
2025-04-24 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-02-04 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-11-22 Departure/Election of Directors; Appointment of Officers; Amendments to Articles of Incorporation or View
2024-10-31 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-07-30 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-05-30 Submission of Matters to a Vote of Security Holders; Other Events; Financial Statements and Exhibits View
2024-04-25 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-02-20 Departure/Election of Directors; Appointment of Officers View
2023-11-28 Departure/Election of Directors; Appointment of Officers View
2023-10-26 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms